VOL. XCIV, NO. 247

★ FINANCIAL TOOLS & SERVICES DIRECTORY ★

PRICE: 5 CENTS

Monday, October 6, 2025

Head-to-head

InvestorGain vs IPOScoop comparison

Compare pricing, supported platforms, categories, and standout capabilities to decide which tool fits your workflow.

Quick takeaways

InvestorGain adds Buybacks & Authorizations, New Issues & Calendars, Blogs, and Education coverage that IPOScoop skips.

IPOScoop includes News, Scores, and Regulatory Filings Monitoring categories that InvestorGain omits.

InvestorGain highlights: Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)..

IPOScoop is known for: IPO Calendar with upcoming and recently priced deals, plus roll-ups like “Last 100 IPOs” and “Last 12 Months.”, SCOOP Ratings (1–5 stars) that reflect the Street’s consensus on expected first-day premiums, with published disclaimers on methodology., and Detailed IPO profiles covering symbol, exchange, share count, price range, underwriters, and historical notes..

InvestorGain ships a mobile app. IPOScoop is web/desktop only.

InvestorGain logo

InvestorGain

investorgain.com

India‑focused IPO & primary‑markets portal with live IPO subscription tracking, Grey Market Premium (GMP) dashboards, anchor investor allocations, and new‑issue calendars (NCDs, SGBs, rights). Provides broker reviews/comparisons and free brokerage calculators. GMP is expressly noted as based on market perception/public sources; the site states it does not work with GMP operators and content is for education/news. The business is ad/affiliate‑supported.

Platforms

Web
Mobile

Pricing

Free

Quick highlights

  • Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
  • Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
  • IPO anchor investor allocation reports by year (mainboard & SME).
  • IPO performance history and GMP‑vs‑actual listing performance trackers.
  • Rights issues dashboard (record date, entitlement, pricing, timelines).

Community votes (overall)

0% upvotes 0% downvotes
You haven't voted yet
IPOScoop logo

IPOScoop

iposcoop.com

Hands-on review

U.S.-focused IPO tracker with calendars, profiles, and editorial coverage. Free sections include the IPO Calendar, Pricings, Last 100, and Last 12 Months. Subscriber access unlocks SCOOP Ratings, quiet-period and lock-up trackers, and certain detailed fields on IPO pages. A corporate XML feed is also available for institutional clients.

Platforms

Web

Pricing

Free
Subscription

Quick highlights

  • IPO Calendar with upcoming and recently priced deals, plus roll-ups like “Last 100 IPOs” and “Last 12 Months.”
  • SCOOP Ratings (1–5 stars) that reflect the Street’s consensus on expected first-day premiums, with published disclaimers on methodology.
  • Detailed IPO profiles covering symbol, exchange, share count, price range, underwriters, and historical notes.
  • Quiet-period and lock-up expiration trackers (specific dates available to subscribers only).
  • Pipeline tools to view IPOs by managers, by industry, or by recent filings.

Community votes (overall)

0% upvotes 0% downvotes
You haven't voted yet
Overlap

Shared focus areas

3 overlaps

Mutual strengths include IPO, Secondary Offerings, and Calendar.

Where they differ

InvestorGain

Distinct strengths include:

  • Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
  • Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
  • IPO anchor investor allocation reports by year (mainboard & SME).
  • IPO performance history and GMP‑vs‑actual listing performance trackers.

IPOScoop

Distinct strengths include:

  • IPO Calendar with upcoming and recently priced deals, plus roll-ups like “Last 100 IPOs” and “Last 12 Months.”
  • SCOOP Ratings (1–5 stars) that reflect the Street’s consensus on expected first-day premiums, with published disclaimers on methodology.
  • Detailed IPO profiles covering symbol, exchange, share count, price range, underwriters, and historical notes.
  • Quiet-period and lock-up expiration trackers (specific dates available to subscribers only).

Feature-by-feature breakdown

AttributeInvestorGainIPOScoop
Categories

Which research workflows each platform targets

Shared: IPO, Secondary Offerings, Calendar

Unique: Buybacks & Authorizations, New Issues & Calendars, Blogs, Education

Shared: IPO, Secondary Offerings, Calendar

Unique: News, Scores, Regulatory Filings Monitoring

Asset types

Supported asset classes and universes

Stocks, Bonds

Stocks

Experience levels

Who each product is built for

Beginner, Intermediate, Advanced

Beginner, Intermediate, Advanced

Platforms

Where you can access the product

Web, Mobile

Web

Pricing

High-level pricing models

Free

Free, Subscription

Key features

Core capabilities called out by each vendor

Unique

  • Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
  • Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
  • IPO anchor investor allocation reports by year (mainboard & SME).
  • IPO performance history and GMP‑vs‑actual listing performance trackers.
  • Rights issues dashboard (record date, entitlement, pricing, timelines).
  • NCD (Non‑Convertible Debenture) issues tracker (coupon, rating, tenor, series).

Unique

  • IPO Calendar with upcoming and recently priced deals, plus roll-ups like “Last 100 IPOs” and “Last 12 Months.”
  • SCOOP Ratings (1–5 stars) that reflect the Street’s consensus on expected first-day premiums, with published disclaimers on methodology.
  • Detailed IPO profiles covering symbol, exchange, share count, price range, underwriters, and historical notes.
  • Quiet-period and lock-up expiration trackers (specific dates available to subscribers only).
  • Pipeline tools to view IPOs by managers, by industry, or by recent filings.
  • Editorial coverage through the “IPO Buzz” blog.
Tested

Verified by hands-on testing inside Find My Moat

Not yet

Yes

Editor pick

Featured inside curated shortlists

Standard listing

Standard listing

Frequently Asked Questions

Which workflows do InvestorGain and IPOScoop both support?

Both platforms cover IPO, Secondary Offerings, and Calendar workflows, so you can research those use cases in either tool before digging into the feature differences below.

Do InvestorGain and IPOScoop require subscriptions?

Both InvestorGain and IPOScoop keep freemium access with optional paid upgrades, so you can trial each platform before committing.

Which tool has mobile access?

InvestorGain ships a dedicated mobile experience, while IPOScoop focuses on web or desktop access.

What unique strengths set the two platforms apart?

InvestorGain differentiates itself with Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)., whereas IPOScoop stands out for IPO Calendar with upcoming and recently priced deals, plus roll-ups like “Last 100 IPOs” and “Last 12 Months.”, SCOOP Ratings (1–5 stars) that reflect the Street’s consensus on expected first-day premiums, with published disclaimers on methodology., and Detailed IPO profiles covering symbol, exchange, share count, price range, underwriters, and historical notes..

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.